Diagnosing Tuberculosis in Children
The diagnosis of pediatric TB is most reliably established through the triad of: (1) a positive tuberculin skin test, (2) abnormal chest radiograph or physical examination, and (3) discovery of a link to a known or suspected case of contagious pulmonary TB. 1
Clinical Approach to Diagnosis
Diagnostic Challenges
- Children with TB often present differently from adults:
- Rarely produce sputum voluntarily
- Typically have low bacterial load (culture-positive in only ~50% of cases)
- Often present with non-specific symptoms
- Radiographic findings differ from adult patterns 1
Essential Diagnostic Components
Tuberculin Skin Testing (TST)
- Recommended interpretation thresholds:
- Important limitations:
Interferon-Gamma Release Assays (IGRAs)
Microbiological Testing
- Early morning gastric aspirates: Culture-positive in approximately 50% of children with TB disease 1
- Acid-fast stains: Positive in only 0-20% of children with TB 1
- Molecular tests (e.g., GeneXpert MTB/RIF): Higher sensitivity than conventional methods 2
- Collection of multiple specimens on different days is recommended 2
Radiographic Evaluation
Source Case Investigation
- Critical for diagnosis and determining drug susceptibility
- Parents and other close contacts should be evaluated for TB disease 1
- Particularly important since TB in young children usually occurs within weeks to months of infection 1
- Helps establish likely drug susceptibility pattern when cultures from child are negative 1
Special Considerations
HIV-Infected Children
- Clinical presentation similar to HIV-negative children but with higher risk of treatment failure and mortality 1
- TST reactivity further decreased by HIV infection 1
- Annual TST recommended beginning at age 3-12 months 1
- Consider IGRAs due to better performance in immunocompromised patients 2
Young Infants
- May present with progressive respiratory distress, apnea, jaundice, and abdominal distention 1
- TST may take 2-3 months after infection to become positive 1
- Incubation period for severe TB (meningitis, disseminated disease) may be only 4-6 weeks 1
- Empiric treatment should be considered for exposed infants with negative TST, particularly those <3 years 1
Drug-Resistant TB
- Diagnosis is either confirmed (isolation of resistant M. tuberculosis) or presumed (clinical evidence plus risk factors) 1
- Risk factors include contact with confirmed/presumed DR-TB source or failure to respond to first-line regimen 1
- Extensive efforts should be made to confirm diagnosis with intensive sampling 1
Diagnostic Algorithm
Initial Assessment
- Evaluate for TB symptoms: persistent cough, fever, weight loss/failure to thrive
- Identify risk factors: TB contact, HIV status, immigration from high-prevalence area
- Perform TST or IGRA
If Positive TST/IGRA or Strong Clinical Suspicion:
- Obtain chest radiograph
- Attempt microbiological confirmation:
- Collect early morning gastric aspirates (3 consecutive days)
- For older children who can produce sputum: collect sputum samples
- Consider alternative specimens based on suspected site of disease
- Identify potential source case and determine drug susceptibility pattern
Diagnostic Decision Making:
- Confirmed TB: Positive culture or molecular test
- Presumptive TB: Based on positive TST/IGRA, compatible clinical/radiographic findings, and TB contact history
- If microbiological confirmation not possible, use the diagnostic triad approach 1
Common Pitfalls to Avoid
- Relying solely on TST results (false negatives occur, especially in young or immunocompromised children)
- Waiting for bacteriological confirmation before initiating treatment in severely ill children
- Failing to investigate potential source cases
- Overlooking extrapulmonary manifestations (lymph nodes, CNS, bone, etc.)
- Using adult diagnostic criteria for children
- Mass testing of low-risk children (leads to false positives and unnecessary treatment) 1
By following this structured approach to diagnosis, clinicians can improve the detection and management of TB in children, leading to better outcomes and reduced morbidity and mortality.